The PharmaSea project is working to make viable drug candidates of novel compounds found under the sea. LSIPR discovers how the EU-funded initiative does it.
We’re running out of new drugs. Since the 1980s, the number of new antibiotics being discovered and making it through the pipeline has been steadily dropping. Meanwhile, disease-causing microbes are becoming resistant to our old drugs.
The World Health Organization fears a “post-antibiotic era”, where common infections and minor injuries can kill. “Far from being an apocalyptic fantasy, is instead a very real possibility for the 21st century,” the organisation said in its April report on microbial resistance.
While there are efforts to tackle this problem from economic and educational angles, some researchers are turning to the world’s oceans in the search for new drug candidates.
You need a subscription to continue reading this content.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
PharmaSea; WHO; antibiotics; generic drugs; antibiotics.